PCI Pharma Services: A global pharmaceutical manufacturing company that develops, manufactures, and packages life-changing therapies for patients all around the world is expanding its campus in Bedford.
PCI Pharma Services acquired Bedford-based life sciences provider Lyophilization Services of New England (LSNE) in December 2021. Following that acquisition, PCI now has its sights on a major expansion plan, with the construction of a 50,000-square-foot facility.
"
The 50,000-square-foot facility will be an extension to one of our existing facilities in Bedford," said Bryan Koeppl, senior vice president of transformation at PCI. "
It will be located in Commerce Park, with construction slated for completion in the summer of 2024".
